NanoKnife Approved for IDE Study

by Savitha C Muppala on  June 24, 2013 at 9:41 AM Medical Gadgets
RSS Email Print This Page Comment
Font : A-A+

A recent device is ready for trial in the U.S which can be a boon for precision ablation of prostate tumors and this could be a good shot in the arm for clinicians.
NanoKnife Approved for IDE Study
NanoKnife Approved for IDE Study

The NanoKnife from AngioDynamics specializes in irreversible electroporation which is nothing but initiating a powerful electric field with a combination of electrodes.

This device enables the entry of ions into the cell interiors and leads to permanent necrosis.

AngioDynamics has not received the FDA approval but they have been given the go ahead with an Investigational Device Exemption (IDE) trial of the NanoKnife for focal treatment of prostate cancer.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive